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1 PHOSPHATIDYLINOSITOL 3-KINASE REGULATES
CA2+ SIGNALING IN PANCREATIC ACINAR CELLS
THROUGH INHIBITION OF SARCO-ENDOPLASMIC
RETICULUM CA2+-ATPASE (SERCA)
Fischer L2, Gukovskaya AS1, Gukovsky I1, Buechler MW2, Friess
H2, Pandol SJ1, (1) Department of Medicine, David Geffen School
of Medicine, University of California, Los Angeles, USA;
(2) Department of Surgery, University of Heidelberg; Heidelberg,
Germany
INTRODUCTION AND AIM: Inhibition of phosphatidylinositol
3-kinase (PI3K) by LY294002 and wortmannin, as well as genetic
deletion of the PI3K gamma isoform (PI3Kg), regulates Ca2+
responses and theCa2+-sensitive trypsinogen activation in pancreatic
acinar cells. The present study sought to determine the mechanisms
of PI3K involvement in Ca2+ responses induced by cholecystokinin-
8 (CCK) and carbachol in pancreatic acinar cells. PATIENTSAND
METHODS: [Ca2+]i was measured either in acinar suspension or
in individual acinar cells. Formation of inositol 1,4,5-trisphosphate
(IP3) was measured by radioimmunoassay. RESULTS: PI3K
inhibitors inhibited both Ca2+ influx and mobilization from intra-
cellular stores induced by stimulation with physiologic and patho-
logic concentrations of CCK, as well as with carbachol. In individual
acinar cells, PI3K inhibition facilitated the decay of [Ca2+]i oscil-
lations. PI3K inhibitors decreased neither CCK-induced IP3
production nor IP3-induced Ca2+ mobilization, suggesting that
PI3K inhibition does not works through IP3 or IP3 receptors.
PI3K inhibition did not affect Ca2+ mobilization induced by
thapsigargin, a specific inhibitor of SERCA. Moreover, SERCA
blockade with thapsigargin abolished the effects of pharmacologic
and genetic PI3K inhibition on [Ca2+]i signals, suggesting
SERCA as a downstream target of PI3K. Pharmacologic PI3K
inhibition as well as genetic deletion of PI3Kg both increased the
amount of Ca2+ in intracellular stores during CCK stimulation.
Finally, addition of PI3K product, phosphatidylinositol 3,4,5-
trisphosphate, to permeabilized acini significantly attenuated Ca2+
reloading into the ER. CONCLUSION: The results indicate that
PI3K regulates Ca2+ signaling in pancreatic acinar cells through
inhibition of SERCA.
2 PANCREATIC ENUCLEATION: EARLY
COMPLICATIONS
Sauvanet A11, Dousset B1, Proye C2, Gigot JF12, Partensky C3, Jaeck
D4, Arnaud JP5, Leborgne J6, Letoublon C7, Fagniez PL8, Berdah
S9, Le Treut YP10, (1) Hospital Cochin; (2) Hospital Huriez, Lille;
(3) Hospital E. Herriot, Lyon; (4) Hospital Hautepierre, Strasbourg;
(5) CHU, Angers; (6) Hoˆtel Dieu, Nantes; (7) Hospital Michallon,
Grenoble; (8) Hospital HenriMondor; (9) Hospital Nord,Marseille;
(10) Hospital Ste Marguerite, Marseille; (11) Hospital Beaujon,
Digestive Surgery, Clichy, France; (12) Clin. Univ. St Luc,
Bruxelles, Belgium
INTRODUCTION AND AIM: Pancreatic enucleation (PE)
seems often associated with pancreatic fistula (PF). This study
aimed to report results of a collective series of PE and to determine
risk factors of PF. PATIENTS AND METHODS: From 1990 to
2003, 113 patients (age=48&#61617;17 years) underwent PE for
72 endocrine tumours (ET), 26 cystadenomas, 5 intra-ductal
papillary and mucinous tumours, lymphangioma/lymphoepithelial
cyst (n=5), or miscellaneous (n=6). PE was performed laparo-
scopically in 10 patients, and was associated with another resection
in 14 (13%, including 6 pancreatectomies ‘re´gle´es’ and 4 multiple
PE). Tumour location was: head (n=42), uncus (n=9), neck
(n=18), or body/tail (n=44). Somatostatine/octreotide was given in
73 patients to prevent PF and abdominal drainage was used in 109.
RESULTS: Mean diameter of tumours was 20&#61617;12 mm
(range: 9–80). Postoperative course was uneventful in 60 (53%)
patients. One patient died (0.9%) from duodenal perforation. PF
occurred in 41 (36%) patients. PF rate was not affected by either
tumour diameter 415 mm, superficial localization (next to
pancreatic capsule), ET type, use of peroperative ultrasound, asso-
ciated pancreatic procedure, use of omental flap, or preventive
administration of somatostatine/octreotide. PF was more frequent
after peroperative ‘visualization’ of Wirsung duct (6/11=55% vs
34%), PE performed on neck (9/18=50% vs 34% for other locali-
zations), and use of open drainage (32/70=46% vs 23% for closed
drainage). PF needed 8 (7%) reoperations and 11 (10%) percuta-
neous drainages. CONCLUSION: PE is associated with a high risk
of PF, particularly for tumours located close to the Wirsung duct or
on the neck. Use of closed suction drainage could be evaluated to
decrease rate of PF.
3 EUS-GUIDED CELIAC PLEXUS BLOCKADE FOR
CONTROL OF PANCREATIC PAIN
Borsodi M, Winternitz T, Nagy E, Darvas K, Kupcsulik P, 1st
Surgical Department, Semmelweis University, Budapest, Hungary
INTRODUCTION AND AIM: Celiac plexus neurolysis and
blockade is used to treat pain caused by pancreatic disease. The aim
of this study is to assess the efficacy of EUS-guided celiac plexus
block for controlling the chronic abdominal pain associated with
chronic pancreatitis and pancreatic cancer. PATIENTS AND
METHODS: 24 patients with upper abdominal pain caused by
pancreatic disease were selected for EUS-guided celiac plexus
blockade. Pain scores were determined pre- and postceliac block.
The EUS celiac block was performed with a 22-gauge sterile Vilman
type needle inserted into the celiac region with guidance of real-time
linear array endosonography followed by injection of 20 ml of
bupivacaine (0.5%) and 7 mg of betamethasonium medially in the
celiac area. RESULTS: A significant improvement in pain scores
with reduction in pain medication usage occurred in 91% (22 of 24)
of patients having EUS block. The mean post procedure follow-up
was 9.5 weeks (range: 4–64 weeks). Persistent benefit was experi-
enced by 58% of patients at 4 weeks and by 25 % at 8 weeks. There
were no complications. CONCLUSION: EUS-guided celiac block
appears to be a safe, effective, and cost-effective method for
controlling the abdominal pain that can accompany chronic
pancreatitis and pancreatic cancer.
4 A NEW TECHNICAL METHOD OF
PANCREATOGASTROSTOMY USING AN ISOPERISTALTIC
GASTRIC TUBE AFTER PYLORUS-PRESERVING
PANCREATODUODENECTOMY
Costa RM, Pereira L, General Surgery, Hospital de Base de Brası´lia,
Brası´lia, Brazil
INTRODUCTION AND AIM: We describe a new surgical tech-
nique for a safer pancreatogastrostomy, which so far has been
performed with no leaks, or other significant complications.
PATIENTS AND METHODS: Our series consists of five men
and three women, with age ranging from 34 to 74 years. Five of
them presented with carcinoma of the head of the pancreas, one
with carcinoma of the papilla of Vater, one with chronic pancreatitis,
and one with a single metastasis to the head of the pancreas from
a primary gallbladder tumor. All patients underwent a pylorus-
preserving pancreatoduodenectomy, two of them had a right
liver lobe resection at the same operation. Following removal of
the specimen, an isoperistaltic gastric tube 75 mm long and 50 mm
wide was created along the greater curvature of the stomach, without
ligation of left gastroepiploic vessels. A length of approximately
4–5 cm of the pancreatic body was dissected, intussuscepted into
the gastric tube and fixed to it with a 2.0 Prolene purse-string suture.
RESULTS: No leakage was detected. One patient presented drain-
age of amylase-rich fluid restricted to the first 2 postoperative days –
355 and 267 I.U/dl, respectively. The nasogastric tube was used
for delayed gastric emptying. In the remaining three patients a
feeding jejunostomy was performed. CONCLUSION: In this
small group of patients, the intussusception of the remnants of
pancreas into a short isoperistaltic gastric tube following a pancre-
atoduodenectomy has been shown to be a simple, effective and
useful technical alternative in avoiding the disruption of the
pancreatogastrostomy.
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5 MANAGEMENT OF A DIFFICULT PANCREATIC STUMP
DURING PANCREATICODUODENECTOMY
Balzano G, Zerbi A, Beneduce AA, Ortolano E, Civelli V, Cristallo
M, Di Carlo V, Surgery, S. Raffaele Hospital, Milan, Italy
INTRODUCTION AND AIM: Pancreatic fistula rate after
pancreaticoduodenectomy (PD) is related to the characteristics of
the pancreas. The aim of the study was to compare different tech-
niques to manage the ‘difficult’ stump. PATIENTS AND METH-
ODS: Retrospective, non-randomised study on prospectively
collected data. Between 2000 and 2004, 285 patients underwent PD.
The difficult stump was defined by soft parenchyma (3 degrees: soft,
normal and hard), with non-dilated duct (1–3 mm). 68 patients with
such characteristics were identified. Three techniques were applied:
A. standard reconstruction (pancreatic, biliary and duodenal
anastomosis on the same loop) (22 patients); B. pancreatico-jeju-
nostomy on a separate Roux-en-Y loop with external Wirsung
stenting (30 patients); C. duct occlusion with prolamine without
anastomosis (16 patients). Fistula was defined as drain output
45 ml, with amylase x5 after day 5. RESULTS: Fistula rate in 68
high-risk patients was higher than in remaining patients (50% vs
16%, p50.001). Mortality was 4.4% and 2.3% (p=0.6). Pancreatic
fistula rate was 41% in group A, 46% in group B and 62% in group C
(p=0.3). The severity of fistula was measured by the fistula-related
mortality and relaparotomy rates: in different groups they were: 22%
and 33% (A); 0% and 0% (B); 10% and 30% (C). The reduction of
major complications in group B was significant (p50.01).
CONCLUSION: In case of a difficult stump, duct occlusion does
not improve the results of standard PD, whereas the Roux-en-Y
anastomosis with externalWirsung stentingmay reduce the dramatic
sequelae of an anastomotic leak.
6 RISK FACTORS FOR COMPLICATIONS IN PATIENTS
UNDERGOING PANCREATIC HEAD RESECTION AFTER
PREOPERATIVE BILIARY DRAINAGE – A MULTIVARIATE
ANALYSIS OF 201 PATIENTS
Makowiec F, Adam U, Hopt U, Department of Surgery, University
of Freiburg, Freiburg, Germany
INTRODUCTION AND AIM: Preoperative biliary drainage
(PBD) may increase complications after pancreatic head resection
(PHR). In some studies PBDwas associated with increased infection
rates or more pancreatic fistulas. To evaluate risk factors we analyzed
postoperative complications in more than 200 patients undergoing
PHR after PBD. PATIENTS AND METHODS: 201 of 462
patients undergoing PHR had had PBD. Operations performed were
pylorus-preserving PD (77%), classical Whipple (9%), duodenum-
preserving resection (13%) and pancreatectomy (2%). Perioperative
data are prospectively documented. Risk factor analysis used current
factors like sex, age, disease (malignant vs benign), diabetes, type of
surgery, type of PBD (percutaneous vs endoscopic), bilirubin and
creatinine (normal vs increased) and transfusions. Multivariate
analysis was performed by binary logistic regression. RESULTS:
Mortality was 2.5%. Postoperative complication rates were 42%
(any), 29% (surgical) and 18% (infectious). Pancreatic leakage
occurred in 12%. Intraoperative bile cultures were positive in 88%.
Multivariate analysis revealed preoperative increased creatinine (in
12%) as an independent risk factor for all types of complication
including pancreatic fistula (p50.05 to 50.01). Further indepen-
dent risk factors were the presence of diabetes (for wound infections
only; p50.05) and malignant disease (for pancreatic fistula only;
p50.04 vs benign disease). Elevated bilirubin and positive bile
cultures did not influence complication rates by either univariate or
multivariate analysis. CONCLUSION: In patients undergoing PHR
after PBD bacterial colonization of the biliary tract and an increased
bilirubin do not influence complication rates.
7 CRITERIA FOR LOCAL AMPULLARY RESECTION AND
PANCREATODUODENECTOMY OF AMPULLARY TUMORS
GumppK1,BehrbohmJ1,WeberE1,TannapfelA2,CacaK3,HaussJ1,
Witzigmann H1, (1) Chirurgische Klinik II, Universita¨tsklinikum
Leipzig; (2) Institut fu¨r Pathologie, Universita¨tsklinikum Leipzig;
(3) Klinik fu¨r Innere Medizin II, Universita¨tsklinikum Leipzig,
Leipzig, Germany
INTRODUCTION AND AIM: Up to 90% of all benign and
malignant ampullary tumors are adenomas or adenocarcinomas.
Because of the different biological features, the rare neuroendocrine
and mesenchymal tumors require an aggressive surgical approach.
The main problem is the pretherapeutic histopathological differ-
entation between adenoma and carcinoma with consecutive ther-
apeutical consequences. PATIENTS AND METHODS: Between
01/1995 and 08/2004 we treated 58 patients with ampullary tumors:
18 adenomas, 34 adenocarcinomas and 6 neuroendocrine tumors (2
carcinoids, 3 somatostatinoma, 1 gangliocytic paraganglioma). The
data of these patients were analysed retrospectively. RESULTS: The
following results refer to the postoperative histopathological findings.
The hospital mortality of all patients was 2% (ampullectomy 0%,
pancreatoduodenectomy (PD) 3%), the morbidity was 16%
(ampullectomy 5%, PD 18%). Adenoma (n=18): Sensitivity of
preoperative biopsies was 89 % (10.5% false negative, they are listed
under adenocarcinoma), the overall accuracy of EUS was 83% (1
patient overstaged, 2 patients understaged). In 17 patients ampul-
lectomy was performed. The hospital mortality/morbidity was 0%/
5%, respectively. Within the mean follow-up of 24 months there was
no recurrence. Carcinoma (n=34): In 45%we obtained preoperative
biopsy. 31/34 patients were treated primarily with PD, in 3/34 we
performed ampullectomy (due to the preoperative biopsy result
adenoma). 2/3 patients were further treated with PD because of R1
resection. The hospital mortality was 3%, morbidity 21%. In 59% of
the patients we found a tumor stage IA-IIA (N0), in 41% a stage dIIB
(N1). The 3-year survival rate for N0 patients was 70% (14/20) and
27% for N1 patients (4/14). Neuroendocrine tumors (n=6): The
preoperative biopsy showed an accuracy of 67%. 2/6 were diagnosed
as adenocarcinoma. 4 patients underwent PD (1 somatostatinoma, 1
carcinoid, 2 patients with preoperative diagnosis of adenocarcinoma
(postoperative: 1 somatostatinoma, 1 carcinoid)). We performed
ampullectomy in the patient with gangliocytic paraganglioma. One
patient with liver metastases was treated palliatively with chemo-
therapy. The hospital mortality/morbidity was 0%/17%, respectively.
The tumor size did not correlate with depth of infiltration and lymph
node metastases. After a mean follow-up of 76 months 4 patients
were without recurrence. The patient treated with chemotherapy was
still alive after 66 months. CONCLUSION: Ampullectomy is the
procedure of choice for ampullary adenomas and acceptable in
individual cases of low-risk T1 carcinoma (G1/G2, L0). Neuro-
endocrine tumors need an aggressive surgical approach (exception:
gangliocytic paraganglioma). Ampullary carcinomas have a 3-year
survival rate after R0 resection of 27% (N1) to 70% (N0).
8 EMERGENCY PANCREATICODUODENECTOMY FOR
COMPLEX PANCREATIC TRAUMA
Krige JE2, Nicol A1, Navsaria P1, JonesO1, Bornman P2, (1) Trauma
Unit, Groote Schuur Hospital, Cape Town; (2) Department of
Surgery, University of Cape Town, Cape Town, South Africa
INTRODUCTION AND AIM: This study evaluated the role of
pancreaticoduodenectomy in the management of complex proximal
pancreatic injuries. PATIENTS AND METHODS: Demographic
data, mechanism and extent of injury, Abdominal Trauma Index
(ATI), Apache II score, operative procedure, postoperative course,
complications and outcome were analysed in 270 patients who had
pancreatic injuries between 1982 and 2003. RESULTS: 17 patients
(15men, 2 women;median age 25 years; 11 gunshot, 4 blunt trauma,
1 stab) had pancreaticoduodenectomy for complex pancreatic injury.
6 had IVC and 3 portal vein or SMV injuries. Four of the 17 patients
required an initial damage control procedure. 12 had a pylorus-
preserving PD and 5 patients had a standard Whipple resection. 9
patients had a pancreaticojejunal anastomosis and 8 a pancreatico-
gastrostomy. The mean ATI was 49 (range 33–79) and median
APACHE score of 0 (range 0–15). The median intraoperative blood
replacement was 12 units (range 8–32). The median duration of
surgery was 5 h 35 min (range 4 h 20 min to 6 h 45 min). Three
patients died postoperatively of multi-organ failure. Complications
included anastomotic leaks due to pancreatic (2), biliary (2) or
duodenal (1) fistulae, delayed gastric emptying (2) and infected intra-
abdominal fluid collections (3). Factors complicating surgery were
shock on admission, the number of associated injuries, coaguloathy,
hypothermia, gross bowel oedema and traumatic pancreatitis. Mean
APACHE II score for survivors was 2 compared to 15 for the 3
deaths. CONCLUSION: Pancreaticoduodenectomy is a life-saving
procedure applicable to a small cohort of patients with complex
unreconstructable or devitalized injuries to the pancreatic head.
APACHE II score accurately predicted mortality.
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9 FINE NEEDLE ASPIRATION BIOPSY OF PANCREATIC
LESIONS: EXPERIENCE OF 2549 CASES
Jaray B1, Szekely E1, Tihanyi T2, Winternitz T2, Tarjan Z3,
Kupcsulik P2, (1) 2nd Department of Pathology; (2) 1st Department
of Surgery; (3) Department of Radiology, Semmelweis University,
Budapest, Hungary
INTRODUCTION AND AIM: An 11-year experience of fine
needle aspiration biopsy (FNAB) in patients with suspected
pancreatic neoplasm is discussed. 2549 FNABs were performed
between 1993 and 2004 at the SemmelweisUniversity ofMedicine in
Budapest. PATIENTS AND METHODS: Most of the biopsies
(83%) were taken intraoperatively, 16% of the procedures were
performed percutaneously with ultrasound guidance and the
remaining patients were examined by US endoscopic-guided biopsy
with Vilman needle. RESULTS: 15% of the smears were insufficient
for diagnosis. Excluding these cases from the overall number of
biopsies, 34% of the biopsies confirmed malignancy, 10% were
suspicious, 56% were benign, including acute and chronic pancre-
atitis, pseudocyst and benign tumour, or showed no pathognomic
alterations. In this series there were no noteworthy complications and
no false positive diagnoses. CONCLUSION: According to the
authors’ knowledge this is the largest number of pancreatic FNABs in
the literature ever published, and they recommend FNAB as a
routine, first level procedure for the diagnosis of pancreatic masses.
10 ROLE OF ENDOSCOPIC ULTRASONOGRAPHY-
GUIDED FINE NEEDLE ASPIRATION FLUID ANALYSIS FOR
DIAGNOSIS OF LARGE PANCREATIC CYSTIC LESIONS
Pukitis A, Pokrotnieks J, Staka A, Gastroenterology Center, Paul
Stradinsh Clinical University Hospital, Riga, Latvia
INTRODUCTION AND AIM: The diagnostic algorithm for
pancreatic cystic lesions is still being evaluated. Endoscopic ultra-
sonography-guided fine needle aspiration (EUS-FNA) is one of the
diagnostic approaches to pancreatic cystic lesions. Cystic content
analysis (cytology, amylase content, CEA, CA19-9) can help to
reliably distinguish between the majority of benign and neoplastic
cystic lesions. Lesions bigger than 20 mm have higher suspicion for
malignancy and were screened according to the inclusion criteria.
PATIENTS ANDMETHODS: In total 25 patients (11 women, 14
men) aged 34–81 years (mean 59 years) with one or more pancreatic
cystic lesions detected by US, EUS, MRI, or CT. were involved. All
pancreatic cystic lesions were considered for single EUS-FNA.
RESULTS: EUS detected pancreas parenchymal echodensity
changes (n=16, 63%), cystic lesions with septae, calcifications, solid
structures (n=9; 37%), pancreatic duct size, structure changes
(n=11; 43%). Surgical treatment n=6 (24%). Cytology study of the
cyst content; malignant cells (n=3, 12%), high-grade adenocarci-
noma (n=1), low-grade adenocarcinoma (n=1), non-Hodgkin
lymphoma (n=1). CONCLUSION: EUS-FNA helps in decision
making for medical or surgical approach. EUS-guided puncture with
single drainage of pancreatic cystic lesions is a simple, safe procedure
(success rate up to 87.5%). EUS-FNA success is dependent on the
cystic content, size, localization and age. Separate CA19-9 and CEA
values showed less diagnostic specificity, combined CEA+CA19-9
and cytology studies enhanced diagnostic sensitivity up to 100%.
11 THE EFFECT OF GLUTAMINE SUPPLEMENTATION
ON SURGICAL OUTCOME AFTER
PANCREATODUODENECTOMY FOR PERIAMPULLARY
TUMOR: PRELIMINARY RESULTS
Jo SH1, Choi SH1, Park S1, Kim EM2, MinMS3, Heo JS1, Seo JM1,
Kim YI1, (1) Surgery, Samsung Medical Center; (2) Dietetics,
Sungkyunkwan University School of Medicine; (3) Pharmacy,
Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul, South Korea
INTRODUCTION AND AIM: Glutamine (Gln) is recognized as a
conditionally essential amino acid maintaining the intestinal mucosal
integrity and enhancing immunologic function in the catabolic state.
However, the effect in patients undergoing major operations has not
been established. This study was designed to assess the effect of Gln
supplementation on surgical outcome after pancreatoduodenectomy
(PD) for periampullary tumor. PATIENTS AND METHODS: A
prospective, randomized and controlled trial was undertaken for
patients undergoing PD or pylorus-preserving PD (PPPD) for peri-
ampullary tumor. They were randomized into the Gln group and the
control group; glycyl-L-Gln of 1.3 g/kg per day was given to the Gln
group for 2 days preoperatively and 5 days postoperatively with
parenteral nutrition (PN), and the control group was given isoni-
trogenous and isoenergetic PN. Surgical outcome was compared by
average length of postoperative stay, complication rate, and chemical
profiles. RESULTS: Of the 86 consecutive patients who underwent
PD/PPPD for periampullary tumor at SMC between February and
October 2004, only 45were enrolled. The patients in both the groups
were comparable prior to the operation. Complication rate of the Gln
group (13.0%) was significantly lower than that of the control group
(50.0%). Average length of postoperative hospital stay was also
shorter by 6.4 days in the Gln group but was not significant. Other
chemical profiles such as serum protein and albumin were not
different between the groups. CONCLUSION: Gln supplementa-
tion may improve surgical outcome after PD/PPPD, but further
studies are necessary for more confirmative results and investigation
of the long-term effect of Gln on cancer prognosis.
12 SEGMENTAL PANCREATIC RESECTION: AN ORGAN-
AND FUNCTION-PRESERVING OPERATION
Mu¨ller MW, Friess H, Kleeff J, Hinz U, Ceyhan G, Bu¨chler P,
Bu¨chler M, Department of General Surgery, University of
Heidelberg, Heidelberg, Germany
INTRODUCTION AND AIM: Pancreaticoduodenectomy or a
distal pancreatic resection is often performed for tumors of the
midportion of the pancreas. However, these procedures result in an
important loss of normal pancreatic parenchyma leading to impair-
ment of both endocrine and exocrine pancreatic function. Therefore
a less aggressive procedure – the segmental pancreatic resection – was
introduced for such cases in order to avoid sparing of functioning
pancreatic tissue. However, a segmental pancreatic resection is
avoided as it has been reported to be associated with a higher
morbidity rate than classic pancreatectomies. PATIENTS AND
METHODS: Between October 2001 and December 2003, the data
from patients undergoing segmental pancreatic resection were
entered prospectively in a database and were analyzed. RESULTS:
25 patients (median age 60 years) with tumorous lesions of the neck
and/or the body of the pancreas received a segmental pancreatic
resection. There were 7 cystic tumors, 3 endocrine tumors, 3
malignant tumors and 12 cases with segmental chronic pancreatitis,
as diagnosed in the final histology. The proximal stump was closed
blindly and the distal stump of the pancreas was anastomosed with a
Roux-en-Y jejunal loop. Postoperative surgical morbidity was 24%
and mortality 0%. Patients operated due to a pancreatic tumor had
significantly (p50.05) more surgical complications than patients
operated for segmental chronic pancreatitis. CONCLUSION:
Segmental pancreatic resection combined with a Roux-Y pancreati-
cojejunostomy to the distal pancreatic remnant is appropriate for
selected patients with benign tumors or neoplasms with low malig-
nant potential. It preserves pancreatic parenchyma and has a
mortality and morbidity rate comparable to other pancreatic resec-
tion procedures.
13 CLINICAL MANIFESTATIONS OF LATENT CELIAC
SPRUEUNMASKEDBYPANCREATODUODENECTOMY(PD)
Pearson RK,Maple J, Division of Gastroenterology and Hepatology,
Mayo Clinic, Rochester, USA
INTRODUCTION AND AIM: Diarrhea and weight loss are
common afterWhipples resection (PD) but profoundmalnutrition is
uncommon. Recently, we evaluated a 57-year-old woman 6 months
after PD (ampullary carcinoid) with intractable diarrhea, a 20-pound
weight loss and confirmed steatorrhea despite pancreatic enzyme
replacement. Jejunal biopsies and serological tests consistent with
sprue coupled with complete resolution of malnutrition and GI
symptoms with gluten withdrawal prompted us to examine the
frequency of this association. PATIENTS AND METHODS: A
retrospective review ofMayoClinic records for the overlap of PD and
celiac disease was performed and the clinical records were examined.
RESULTS: From 1975 to 2004, seven patients were identified who
developed classic histologic changes of celiac sprue after PD. Patients
did not have a diagnosis or a suspicion of celiac sprue before surgery
or from pathological review of the resected duodenal specimen. All
developed steatorrhea (mean: 57 g stool fat/24 h; range 31–92),
hypoalbuminemia (mean: 2.4 g/dl; range 1.9–3.5) and classic
histologic changes of celiac disease including villous atrophy and
intra-epithelial lymphocytosis after surgery. A delay in the diagnosis
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after surgery was common, ranging from 6 months to 10 years after
PD. Three patients required temporary parenteral nutritional
support due to the severity of malnutrition. Clinical improvement
in most patients was observed with gluten withdrawal. CON-
CLUSION: Latent celiac disease should be considered in the
differential diagnosis of significant diarrhea and weight loss after PD.
14 ADENOCARCINOMA OF THE DUODENUM
Ramia JM1, Muffak K1, Villar2, Serradilla M1, Garrote D1, Ferro´n
JA1, (1) General Surgery; (2) Surgery, University Hospital Virgen de
las Nieves, Granada, Spain
INTRODUCTION AND AIM: Adenocarcinoma of the duodenum
is an infrequent neoplasm. There are not many large series to obtain
clear conclusions. The aime was to evaluate our experience in AD.
PATIENTS AND METHODS: Retrospective study of 5 cases
diagnosed in our department in the period 1999–2003. RESULTS:
Mean age was 54 years (18–69). 80% were male (4/5). All of them
suffered loss of weight, and abdominal pain. The only female was
affected from familial polyposis. Preoperative mean hemoglobin was
11.1 g/dl (6.3–13.2 g/dl). Only one patient was jaundiced. Diag-
nostic methods were: upper endoscopy plus biopsy (5/5), barium Rx
(2/5), ultrasound (5/5) and CT (4/4). CT and endoscopy were the
most accurate diagnostic methods. The tumor was located in: 2o
portion (3) and 3a portion (2). Preoperative diagnosis was correct in
every case. Surgical procedures were: pancreatoduodenectomy (3
cases), duodenectomy plus atypical pancreatic resection and right
hemicolectomy (1 case). One patient with bilobar liver metastases
was not operated on. Surgical time was 6 h 15 min (4, 8 h). No
transfusio´n was done. Two patients presented postoperative
complications: delayed emptying and remnant pancreatitis that
evolved to SIRS and led to death. Mean tumoral size was 5.9 cm.
pTNMwere T4N1M0, T3N1M0, T3N0M0, T2N0M0. Survival of
living patients is 60, 13 y 2 month. No relapse has been observed in
follow-up. CONCLUSION: Duodenal adenocarcinoma has better
survival than other periampullary neoplasms. Pancreatoduode-
nectomy is the treatment of choice tumor is 2nd portion.
15 ARE THERE PANCREATIC STEM CELLS?
Yalniz M, Pour PM, UNMC/Eppley Cancer Center, University of
Nebraska Medical, Omaha, NE, USA
INTRODUCTION AND AIM: A vast number of studies indicate
the presence of stem/progenitor cells virtually in all tissues in adult
organs, particularly in bone marrow. Recent studies, however, cast
doubt about the existence of true stem cells in adult tissues. The
complex integrity of several cells with distinct morphologic and
functional properties in the mature pancreas confers an appropriate
status for stem cell research. Although several different types of cells
residing in the islets or in the ductal epitheliumhave been proposed as
adult pancreatic stem cells or progenitor cells, the results are illusive.
PATIENTS ANDMETHODS: An extensive review of the past and
current literature was performed and our own in vitro and in vivo
studies in animals and humans were included. RESULTS: The
published reports do not provide conceivable proof for the presence
of true pancreatic stem cells. On the other hand, there is considerable
evidence indicating transdifferentiation of all adult pancreatic cells
into each other, and under proper conditions, to non-pancreatic cells
including oncocytes and hepatocytes. Our own studies during the last
20 years strongly did not reveal any pancreatic cells that could be
regarded as stem cells. However, the results point to the transdif-
ferentiation pathway during pancreatic cell renewal, regeneration
and malignancy. CONCLUSION: Observations pertaining to
putative pancreatic stem cells, transdifferentiation ability of the
differentiated mature pancreatic cells in the normal and diseased
pancreas will be discussed and our own findings supporting the
transdifferentiation pathway will be presented.
16 RARE DISEASE, RARE SOLUTION: ULTRASOUND-
GUIDED DOUBLE-PIGTAIL DRAINAGE OF PANCREATIC
PSEUDOCYST IN CHILDHOOD
Winternitz T, Borsodi M, Tihanyi T, Kupcsulik P, 1st Surgical
Department, Semmelweis University, Budapest, Hungary
INTRODUCTIONANDAIM:Although lesions of the pancreas are
rare injuries in childhood, serious pancreatic lesions should be
considered after blunt abdominal trauma initially. The typical feature
of rupture of the pancreas is characterized by fall on a bicycle
handlebar and a round circumscript sign in the upper abdomen.
PATIENTS AND METHODS: We performed ultrasound and
endoscope guided double-pigtail drainage (Hancke) of pancreatic
pseudocysts on 3 children aged 13, 13 and 17 years, respectively. The
pseudocysts were 12.5, 8, and 10 cm in diameter. The aetiology of
pancreatic pseudocysts was abdominal trauma at all the cases.
Ultrasound and CT scans confirmed the diagnosis and suitability for
drainage. After the US-guided percutaneous puncture, a ‘Hancke’-
type double pig-tail catheter was placed for the permanent drainage,
the perfect localisation of the catheter was observed by endoscope.
RESULTS: Complete regression was confirmed by follow-up
ultrasonography at 14, 4, and 5 weeks, respectively. There were no
procedure-related complications, nor was there a recurrence of cyst
during the 7–12 years of follow-up. CONCLUSION: This report
suggests that children with nonresolving pancreatic pseudocysts, that
are anatomically accessible, can be treated successfully and safely by
ultrasound and endoscope guided drainage.
17 EVALUATION, SURGICAL APPROACHES AND
RESULTS OF TREATMENT OF PANCREATOLITHIASIS IN
110 CONSECUTIVE PATIENTS – EXPERIENCE OF A
HEPATO-BILIARY-PANCREATIC SURGERY UNIT
Ali M, Birdem, Department of Hepatobiliary and Pancreatic
Surgery, Dhaka, Bangladesh
INTRODUCTION AND AIM: Patients with pancreatolithiasis are
mostly young and in active state of life. Calcific lithiasis is usually
associated with diabetes, malnutrition, alcohol, heredity and idio-
pathic pancreatitis. Long continued lithiasis with pancreatitis might
also cause bile duct obstruction, duodenal obstruction, splenic vein
thrombosis, pancreatic ascites, peripancreatic abscess, pseudocyst,
exocrine and endocrine deficiency. The aim of this study is to
evaluate the treatment strategies and results of patients with
pancreatolithiasis in a hepato-biliary-pancreatic surgery unit in
Bangladesh. PATIENTS AND METHODS: The management of
110 consecutive patients with pancreatic calculi in the last 80months
in BIRDEM hospital, Dhaka. 95 patients (86.4%) were diabetic,
they were evaluated clinically and by imaging studies, endoscopic
retrograde cholangiography (ERCP), computerized tomography
(CT), tumourmarkers and glycaemic status. Roux-en-Y longitudinal
pancreato-jejunostomy done in 96 (87.2%), distal pancreatectomy in
3 (2.7%), partial pancreatoduodenectomy (Whipple’s procedure) in
2 (1.8%), pancreato-jejunostomy and hepatico-jejunostomy in 5
(4.5%), revision pancreato-jejunostomy after dismantling the
previous anastomosis in 4 (3.6%). Biopsy was taken from the
pancreatic duct of all the patients. There were additional procedures
like celiac ganglion block in 25 (22.7%), cholecystectomy in 10
(9.1%), choledocholithotomy in 3 (2.7%), and internal drainage of
pseudocyst in 1 (0.9%) patient. RESULTS: Good pain relief was
obtained in 83 (75.5%) patients, moderate in 22 (20%), and poor in
5 (4.5%). One patient had bleeding pancreato-jejunostomy 2 weeks
after surgery. It was controlled by peroperative enteroscopic home-
ostasis without dismantling the anastomosis. CONCLUSION:
Well-planned surgery for pancreatic calculi can offer good pain relief
and definitive management of associated disorders.
18 POSSUM SCORING SYSTEMS IN THE EVALUATION
OF MORBIDITY AND MORTALITY IN PANCREATIC
SURGERY
Wickremesekera K, Wan A, Kourliouros A, Thompson J, Upper GI
Surgery, Royal Marsden Hospital, London, UK
INTRODUCTION AND AIM: Prediction of morbidity and
mortality after pancreatic cancer surgery is often imprecise. A scoring
system such as POSSUM often over-predicts mortality. The
Portsmouth modification of the POSSUMwas proposed to improve
correlation with actual outcome in mortality. The objective of
this study is to apply POSSUM and P-POSSUM to a group
of patients undergoing pancreatic surgery and evaluate their accuracy
in predicting outcome. PATIENTS AND METHODS: We
performed a retrospective analysis on 52 patients who underwent
pancreato-duodenectomy for both benign andmalignant conditions.
Physiological and operative severity scores were entered into
POSSUM and P-POSSUM to calculate the predicted peri-
operative risks of morbidity andmortality. The predicted values were
compared with the observed values. RESULTS: The mean physio-
logical score was 16.9+4.4 and the mean operative severity
score was 21.6+2.8. There were 23 complications and 2 deaths.
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POSSUM score predicted a morbidity risk of 67.4% and the
actual risk was 42.3% (p=0.07, CI=0.9–4.6). The predicted
mortality by P-POSSUM was 7.4% compared with an
observed value of 3.6% (p=0.68, CI=0.4–11.8). CONCLUSION:
The predicted morbidity and mortality derived from the
scoring systems did not differ significantly from the observed
events at our centre. However, as our sample size was small and
the confidence intervals for the risk scores were wide, a larger
study and subgroup analysis may be required to allow any further
conclusions to be drawn for these patients undergoing pancreatic
surgery.
19 PANCREATIC RESECTION FOR PANCREATIC
METASTASES FROM BREAST AND OVARIAN CARCINOMA
Bonardi C2, Mussi C1, Angelini C1, Sartori P1, Caprotti R1, Uggeri
F1, (1) Surgery, University of Milan-Bicocca, Segrate;
(2) Gynaecology, University of Milan-Biocca, Segrate (MI), Italy
INTRODUCTION AND AIM: Metastases to the pancreas are rare
and their resection can be performed as a palliative treatment. The
aim of this study was to review our experience with the operative
management of pancreatic metastases from gynaecological malig-
nancies. PATIENTSANDMETHODS: Between January 1990 and
December 2002 four patients underwent pancreatic resection for
pancreatic metastases from breast carcinoma (n=3) and from ovar-
ian carcinoma. RESULTS: In all cases, pancreatic metastases were
symptomatic and metachronous and the intervals between primary
tumour and pancreatic metastases were 1.5, 3, 5 and 7 years,
respectively. Primary tumor was lobular breast carcinoma (n=3) and
endometrioid carcinoma of the ovary (n=1). In all cases the
pancreatic tumor was resected with intention to cure or provide
useful palliation using distal pancreatectomy with splenectomy in the
patient with ovarian metastasis and pylorus-preserving pancreatico-
duodenectomy in the remaining three. Adjuvant chemotherapy was
performed in three cases. Regarding patients with primary breast
carcinoma, one died fromdisseminatedmetastatic disease 22months
after pancreatic resection; the remaining two patients remain alive 40
and 24 months after pancreaticoduodenectomy and the second one
developed recurrence of disease. The patient with primary ovarian
carcinoma was in good health for 5 years when she was operated for
colonic carcinoma. She died from liver metastases. CONCLUSION:
Pancreatic resection can be performed safely in patients with symp-
tomatic and isolated metastases in the absence of widely metastatic
disease. Surgical treatment, combined with systemic therapy, can
provide worthwhile palliation and improve survival.
20 RESULTS OF THE SURGICAL MANAGEMENT OF
METASTATIC RENAL CELL CARCINOMA TO THE
PANCREAS
Dobrowolski F, Saeger HD, General Surgery, University Hospital
Carl Gustav Carus, Dresden, Germany
INTRODUCTION AND AIM: Generally the prognosis of meta-
static renal cell carcinoma is poor. Mostly a curative treatment is
not possible and surgical treatment is limited to palliative options.
Metastasis to the pancreas is rare and frequently associated with
metastatic involvement of other locations. In case of a solitary
manifestation to the pancreas surgical treatment should be taken
into account. We present our data on the surgical treatment
of metastatic renal cell carcinoma to the pancreas. PATIENTS
AND METHODS: From 10/1993 to 7/04 we have performed
7 pancreatic resection procedures (3 pancreatic head resections, 1
pancreatic segmental resection, 1 left pancreatic resection, 1 total
pancreatectomy, 1 resection of the ampulla vateri). The median age
was 62 years. The median interval between the nephrectomy and
the pancreatic resection was 5 years (min. 1.5 years, max. 7.5 years).
RESULTS: The median survival was 49 months (min. 1 month,
max. 116 months). One patient died perioperatively because
of a septic complication after pneumonia. There was 1
postoperative bleeding, 1 pancreatic fistula and 1 wound abscess.
CONCLUSION: The results of this selective group of patients
with surgery for metastatic renal cell carcinoma to the pancreas
are better than for ductal adenocarcinona of the pancreas. Therefore
a resection procedure should always be taken into account
for patients with a solitary metastasis to the pancreas and an accep-
table operative risk.
21 OSTEOCLAST-LIKE GIANT CELL TUMOR OF THE
PANCREAS
Turashvili G, Burkadze G, Pathology, Tbilisi State Medical
University, Tbilisi, Georgia
INTRODUCTION AND AIM: Osteoclast-like giant cell tumor of
the pancreas is a rare entity, with a frequency of only 0.2% of the total
reported pancreatic carcinomas. The lesionmost commonly presents
as large cystic neoplasm, 5–10 cm in diameter. It is frequently
associated withmucinous cystic neoplasms and in situ and infiltrating
adenocarcinomas. Histologically, these tumors are composed of
multinucleated, benign appearing, osteoclast-like giant cells
dispersed among infiltrating mononuclear tumor cells. The question
of whether the giant cell component is neoplastic or reactive is
controversial. The aim of our study was to investigate the protein
expression profile of osteoclast-like multinucleate giant cells in
mucinouc cystic neoplasm of the pancreas. PATIENTS AND
METHODS: Archival paraffin blocks from 3 patients with cystic
neoplasms of the pancreas were studied. Surgical specimens were
fixed in 10% buffered formalin, embedded in paraffin and cut in 4-
mcm sections. Hematoxylin and eosin-stained section slides were
prepared for histological evaluation, and the clinical histories were
reviewed. Immunohistochemical stains were performed using the
LSABmethodology (substrateDAB)with primary antibodies against
vimentin, CD68, CD45, EMA, MNF116, CEA, NSE, alpha-
smooth muscle actin, S100, Ki-67 (DakoCytomation). RESULTS:
Microscopically, the neoplasms had two distinct components: a
mucinous, neoplastic epithelial cyst with nodular areas of multi-
nucleate tumor giant cells. The mucinous epithelium showed a few
areas of moderate atypia, pseudostratification without the suggestion
of invasion into the stroma, intraluminal papillary formations, goblet
cells, with ovarian-like hypercellular stroma. Themultinucleate giant
cells resembled the bone osteoclasts with no signs of atypia. Immuno-
histochemically, the mucinous epithelial cells stained for EMA and
MNF116, but not for CEA. The multinucleate giant cells were
positive for vimentin and cell surface proteins CD68 and CD45, and
negative for MNF116 and epithelial membrane antigen (EMA). An
immunohistochemic profile of multinucleate giant cells is consistent
with a mesenchymal phenotype. The spindle cells of hypercellular
stroma were stained for vimentin, but not for EMA or CEA. The
mononuclear stromal cells expressed alpha-smooth muscle actin
focally. CEA, NSE, S100 and Ki-67 showed no reactivity. The final
histopathological diagnosis was ‘borderline mucinous cystadenoma
with osteoclast-like giant cells’. CONCLUSION: Osteoclast-like
multinucleate giant cells in mucinous cystic neoplasms of the
pancreas possess cell-surface markers: CD68, CD45, as well as
vimentin, which suggests their origin from macrophage lineage. The
osteoclastic tumor giant cells appeared to arise on a background of a
mucinous neoplastic epithelial component. The reported cases
suggest that different biological mechanisms may be responsible for
osteoclast-like giant cell tumor in mucinous cystadenoma and pleo-
morphic giant cell carcinoma, which contains multinucleate giant
cells of epithelial lineage.
22 EFFICACY OF THE ESSENTIAL PHOSPHOLIPIDS
(EPL) IN TREATMENT OF CHRONIC ISCHEMIC LESION OF
LIVER AND PANCREAS
Gubergrits NB, Agapova N, Chair of Internal Diseases No. 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: Abdominal ischemic syndrome is a
frequent cause of digestive tract pathology in elderly people suffering
from atherosclerosis. Aim: to assess therapeutic results of preparation
Essentiale N (based on EPL) in ischemic hepatopathy and
pancreatopathy. PATIENTS AND METHODS: We observed 60
patients with abdominal ischemic syndrome. The diagnosis was
proved by dopplerography. 30 of the patients (main group) received
nitrates + Essentiale N. Another 30 patients (comparative group)
were given nitrates alone. There the following indices were control-
led: blood lipid spectrum, transaminases (ALT,AST), blood levels of
gamma-glutamyl transpeptidase (GGT), bilirubin, albumin, activity
of blood pancreatic isoamylase, lipase, faecal elastase-1, evaluated
coproscopy before and after the treatment. RESULTS: Patients in
the main group earlier and in most cases had the pain syndrome
reduced. After a course of Essentiale N patients in the main group
had reliable decrease of cholesterol and low density lipoprotein blood
levels. Whereas patients of the comparative group had no reliable
changes in blood lipids spectrum. Inclusion of Essentiale N in the
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therapeutic scheme promotes normalization of ALT and AST
indices, reduction of GGT, bilirubin and elevation of albumin blood
levels. Under the influence of the main treatment course the intensity
of enzymes’ ‘deviation’ to blood phenomenon had reduced and a
tendency to increasing of the faecal elastase-1 level and reduction of
steatorrhea was observed. CONCLUSION: Inclusion of the
preparation based on EPL – Essentiale N – into the treatment course
of patients suffering from abdominal ischemic syndrome promotes
the reduction of intensity of ischemic hepatopathy and pancreato-
pathy.
23 STAGED INJURY REPAIR (STIR) IN THE TREATMENT
OF SEVERE GUNSHOT INJURIES OF THE PORTAL VEIN,
PANCREAS AND LIVER: CASE REPORT
Karamarkovic AR, Djukic V, Radenkovic D, Jeremic V, Stepic D,
3rd Surgical Department, University Center for Emergency Surgery,
Belgrade, Serbia & Montenegro
INTRODUCTION AND AIM: Staged injury repair (STIR) is the
new concept, defined as one operation performed in multiple steps to
permit delayed definitive repair after initial damage control in non-
stable patients. PATIENTS AND METHODS: Case report: A 37-
year-old woman was admitted, with gunshot injury of the upper
abdomen, with signs of severe hemorrhagic shock. During the initial
emergency operation we discovered lesions of the left liver, isthmic
pancreas, and also injury of the portal vein at the level of splenic vein
confluence. The portal vein was successfully reconstructed with
Prolene 5-0 interrupted sutures. Then a left spleno-hemi-
pancreatectomywas performed. The lesion of the liver was treated by
hepatorrhaphy. Due to the unstable condition of the patient, peri-
hepatic packing was done. Temporary abdominal closure was
performed utilizing a glider (ETIZIP). During the first re-exploration
24 h later, perihepatic packing was removed, and on that occasion
the lesion of segmental pedicle (S3) within the umbilical fissure, with
bile leakage and bleeding, was discovered. Under stable hemody-
namic condition of the patient, segment S3 of the liver was removed
(Segmentectomy S3). On the second re-exploration 48 h later, we
found the resected liver and pancreas completely normal, with no
signs of bleeding and leakage. The postoperative course of the patient
was excellent. The control Doppler US registered normal blood flow
through the SMV and PV. The patient was discharged on the 8th
postoperative day. CONCLUSION: The STIR concept with possi-
bilities of multiple explorations and delayed repair, proved to be
successful in the management of severe abdominal injuries.
24 A PANCREATIC MUCINOUS CYSTADENOMA IN A
MAN WITH MESENCHYMAL STROMA, EXPRESSING
OESTROGEN AND PROGESTERONE RECEPTORS
Fujimoto K3, Adachi Y1, Sakurai T1, Maetani Y2, Doi R3,
(1) Diagnostic Pathology, Kyoto University; (2) Nuclear Medicine
and Diagnostic Imaging, Kyoto University; (3) Surgery and Surgical
Basic Science, Kyoto University, Kyoto, Japan
INTRODUCTION AND AIM: According to the 2nd edition of
Histological Typing of Tumours of the Exocrine Pancreas published by
the WHO in 1996, it has been defined that mucinous cystic
neoplasms occur almost exclusively in middle-aged women,
composed of columnar, mucin-producing epithelium with ovarian-
type stroma. Here, we present a pancreatic mucinous cystadenoma
with mesenchymal stroma, expressing oestrogen and progesterone
receptors, in a male patient. PATIENTS AND METHODS: A
38-year-old man was admitted in April 2004 with recurrent episodes
of upper abdominal pain. The patient did not show any external signs
of feminization. Laboratory investigations showed no increase of
serum amylase and lipase. Radiological examination revealed
multilocular cystic lesion with enhancement of the internal thin
septa, which was resected. RESULTS: Gross examination showed a
multilocular cystic lesion measuring 8.0 cm in diameter and
containing hazy gelatinous fluid. Microscopically, a mucinous
cystadenoma with ovarian-type stroma was diagnosed. The lesion
showed two different components: a cyst lined by a columnar,mucin-
secreting epithelium and a moderate cellular stroma composed of
spindle cells similar to ovarian stroma. Immunohistochemically, the
epithelium was positive for MUC 5 and 6 and the stroma were
stained with alpha-inhibin, oestrogen and progesterone receptor
antibodies. CONCLUSION: Cystadenomas with mesenchymal
stroma are uncommon in the pancreas, and primarily occur in
women. However, in our male case, immunoreactivity of the
mesenchymal stroma for oestrogen and progesterone was found. It is
necessary that definitions of mucinous cystadenomas of the pancreas
are discussed all over again.
25 PRIMARY ADENOCARCINOMA OF THE DUODENUM:
REPORT OF 3 CASES
Potrc SS, Ivaecz A, Horvat M, Gadzijev E, KorenM, Department of
Abdominal Surgery, Teaching Hospital Maribor, Maribor, Slovenia
INTRODUCTION AND AIM: Primary adenocarcinoma of the
duodenum is extremely uncommon, occurring in 0.019–0.5% of all
autopsy cases. Most of these tumors are sporadic with the exception
of those originating in the context of familial adenomatous polyposis.
We present three patients operated in our institution for tumors in the
pancreaticoduodenal region. The pathohistological examination
revealed primary carcinoma of duodenum for all three patients.
PATIENTS ANDMETHODS: Three patients (two males aged 44
and 52 years and one female aged 73 years) were referred for surgical
treatment of the tumor mass in the pancreaticoduodenal region. The
leading symptom in the younger male and the female patient was
jaundice. The 52-year-old patient’s main complaint was upper
abdominal discomfort. Complete diagnostic work-up regarding
suspected tumormass in the pancreaticoduodenal region was carried
out in all of them (tumor markers, ultrasound, ERCP, CT, endo-
scopic ultrasound, endoscopy of the stomach and duodenum with
biopsy). RESULTS: Pylorus-preserving pancreatoduodenectomy
was performed in both male patients and the classic Whipple
procedure in the female patient. Postoperative course was uneventful
in all three patients. In all three the diagnosis of the primary adeno-
carcinoma of duodenumwas established postoperatively on the basis
of the pathohistological examination of the resected specimen.
CONCLUSION: Duodenal carcinoma is a rare tumor. Due to non-
specific symptoms and its rarity the diagnosis is often delayed and
confused with papillo-ampullary and pancreatic malignancy. There
are some controversial reports about its biological behavior but most
authors agree that an aggressive approach in terms of R0 resection is
justified even in the advanced stages.
26 PREOPERATIVE IMAGING AND LOCALIZATION OF
SMALL SIZED INSULINOMA WITH EUS-GUIDED FINE
NEEDLE TATTOOING: A CASE REPORT
Zografos GN2, Karoubalis J1, Koliopanos A2, Mitropapas G2,
Kaltsas G3, Papastratis GI2, (1) Department of Gastroenterology;
(2) ThirdDepartment of Surgery; (3) Department of Endocrinology,
Athens General Hospital, Athens, Greece
INTRODUCTION AND AIM: We report a case of a small insuli-
noma that CT scan and MRI did not image. PATIENTS AND
METHODS: Endoscopic ultrasonography (EUS) revealed a small
insulinoma located at the body of pancreas. Preoperatively, a new
EUSwas done and the tumor was injected with blue dye. The patient
was then taken to the operating room and underwent exploratory
laparotomy. RESULTS: The insulinoma was easily found at the
posterior aspect of the pancreas close to the left side of the portal vein
and excised. The size was 8r8 mm and histology further confirmed
the diagnosis. The patient had a smooth postoperative period and did
not have recurrent hypoglycemia 2 years after surgery. CONCLU-
SION: Only few reports are recorded in the literature with the above
technique. Technical aspects and therapeutic alternatives are high-
lighted.
27 DUODENUM-PRESERVING PANCREAS HEAD
RESECTION FOR CYSTIC NEOPLASMS
Kainuma O, Asano T, Yamamoto H,Mori M, NagataM, Takiguchi
N, Soda Hiroaki, Murakami K, Doki T, Digestive Surgery, Chiba
Cancer Center, Chiba, Japan
INTRODUCTION AND AIM: Cystic neoplasms of the pancreas
are increasingly detected with recent developments of the imaging
modality. Most of these diseases are considered to be benign or low-
grade malignant. We have performed minimally invasive operation
that implies partial resection of the pancreas head and preservation of
the duodenum and the bile duct. We show here a video of the
procedure of duodenum-preserving pancreas head resection
(DpPHR). PATIENTS AND METHODS: A 76-year-old female
with no complaint was admitted to our hospital. US showed a 4-cm
multilocular cystic mass at the pancreas head. Endoscopic ultra-
sound did not show papillary projection on the cyst wall. MRCP
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showed no dilatation of the main pancreatic duct. The patient was
preoperatively diagnosed as suspicious of branch type of intraductal
papillary mucinous neoplasm or serous cystadenoma. RESULTS:
Operation was done with upper median skin incision. The size and
location was evaluated by intraoperative ultrasonography. Anterior
inferior pancreaticoduodenal artery and posterior inferior pancre-
aticoduodenal artery were taped. The pancreatic branches of those
were carefully ligated and divided. The duct of Wirsung was ligated
and divided. The bile duct was taped, subsequently pancreas excision
was performed along the lower bile duct. The duct of Santorini was
ligated and divided. Dissection between the pancreas head and the
mesoduodenum was performed. The pancreas was devided using a
harmonic scarpel at the right side of the superior mesenteric vein.
After excision of the pancreas head, the pancreatic duct was
anastomosed to the jejunal wall with 6-0 monofilament threads. The
jejunum was reconstructed in Roux-Y fashion. The intraoperative
blood loss was 305 g. Postoperative course was uneventful.
CONCLUSION: This procedure is safe and effective for benign or
low-grade pancreas disease. Preservation of the pancreatic vessel
arcade and careful anastomosis are important in this operation.
28 HEMORRHAGIC SHOCK CAUSED BY MASSIVE
BLEEDING OF TWO SYNCHRONOUS STOMACH
LEIOMYOMA – CASE REPORT
Jovanovic MM, Zajic S, Department of Surgery, Health Center
Krusevac, Krusevac, Serbia and Montenegro
INTRODUCTION AND AIM: Upper gastrointestinal bleeding
(bleeding inside oesophagus, stomach or duodenum) presents as
hematemesis or melaena unless bleeding is insignificant (occult
bleeding). Oesophagus, stomach and duodenum represent 10% of
total length, and 5%of surface of gastrointestinalmucosa, but 80%of
bleeding from the gastrointestinal tract is upper gastrointestinal
bleeding. Upper gastrointestinal bleeding can be followed by hypo-
volemic shock (paleness, cold sweat, superficial rapid breathing,
filiform pulse over 100 beats a minute, systolic blood pressure under
100 mmHg) and acute anemia (Hb less than 8 g/L, Er less than
2.5r109). According to some percentages every day in a hospital
that covers about 300,000 and more inhabitants one patient asks for
help with symptoms and signs of upper gastrointestinal bleeding.
Leomyoma are often submucosal benign neoplasmas of the stomach.
They are often without any symptoms, but they can be the reason for
bleeding. PATIENTS AND METHODS: We retrospectively
analysed History of desease and Operative protocol. RESULTS: We
present the case of a patient aged 77 years who was operated by an
urgent surgical intervention because of the haemorrhagic shock that
was caused by massive bleeding from two synchronous leomyoma of
the stomach. CONCLUSION: Urgent surgical treatment gives the
possibility of definitive cure.
29 THE NARDI TEST FOR SPHINCTER OF ODDI
DYSFUNCTION: WORTH THE PAIN?
Takhar A1, Lobo DN1, Thaper A1, Rowlands BJ1, (1) Section of
Surgery, University Hospital Nottingham, Queen‘s Medical Centre,
Nottingham, UK
INTRODUCTION AND AIM: The Nardi (morphine-prostigmine
provocation test) is used to diagnose sphincter of Oddi dysfunction
(SOD) and a positive test is characterised by reproduction of
abdominal pain with a four-fold increase in serum amylase or lipase.
This study was performed to characterise the biochemical and clin-
ical response in healthy subjects. PATIENTS AND METHODS:
Baseline serum amylase and lipase concentrations were measured in
20 healthy adult volunteers who had abstained from alcohol for 24 h.
After performing a control test, 10 mg morphine and 1 mg pros-
tigmine were administered intramuscularly, and blood was sampled
for enzyme measurements every hour for 5 hours. Symptoms were
recorded. Results were compared with Nardi test results from 20
patients with known SOD. RESULTS: The median age of the 20
volunteers (6 female) was 21 (18–23) years. A greater than four-fold
postprovocation increase in serum lipase and amylase was recorded
in 75% and 65%of volunteers, respectively. In comparison, 85% and
45% of patients with SOD had a greater than four-fold increase in
serum lipase and amylase. There was no significant difference in the
maximum post provocation serum lipase (p=0.2) and amylase
(p=0.3) concentrations in the two groups (Mann-Whitney U test).
While all patients complained of abdominal pain during the test,
none of the volunteers experienced pain. CONCLUSION: Pain is
the major determinant of a positive Nardi test in the diagnosis of
SOD, given that the changes in biochemical parameters are similar in
healthy volunteers.
30 TECHNICAL ASPECTS OF DISTAL
PANCREATECTOMY
Zografos G, Tsipras H, Margaris E, Koliopanos A, Ageli C,
Kothonidis K, Antypa E, Papastratis G, Papastratis G, General
Hospital, Athens, Greece
INTRODUCTION AND AIM: From 1997 to 2004, 25 patients
underwent distal pancreatectomy in our unit. PATIENTS AND
METHODS: There were 11 women and 14 men aged from 46 to 81
years. Indications for surgery were adenocarcinoma of the pancreas
12, chronic pancreatitis 3, gastric cancer 3, lower oesophageal cancer
2, cystadenoma of pancreas 2, cystadenocarcinoma 1, pancreatic
pseudocyst 1 and adrenal cancer 1. RESULTS: Nine patients
developed pancreatic fistula, without clinical manifestations,
conservatively treated. One patient with locally advanced oesopha-
geal cancer succumbed to sepsis 1 month after oesophagogas-
trectomy, distal pancreatectomy and splenectomy. CONCLUSION:
Distal pancreatectomy is associated with a low mortality rate.
Morbidity is related to the pancreatic fistula rate although septic
complications are rare. Technical aspects of the procedure focusing
on pancreatic stump closure are discussed.
31 INTRADUCTAL PAPILLARY MUCINOUS TUMORS OF
THE PANCREAS
Tsipras H, Zografos GN, Koliopanos A, Karoubalis J, Ageli C,
Kothonidis K, Papastratis G, hird Department of Surgery, Athens
General Hospital, Athens, Greece
INTRODUCTION AND AIM: Intraductal papillary mucinous
tumors (IPMTs) are more frequently recognized and reported since
they were defined and classified by the WHO as a distinct entity of
cystic pancreatic neoplasms. The potential to diffusely involve the
pancreatic duct questions partial resection as adequate surgical
treatment. We present hereby a case of IPMT, in a patient who was
treated successfully with total pancreatectomy. PATIENTS AND
METHODS: A 31-year-old male was investigated for a diarrheic
syndrome with early onset. Clinical and laboratory studies as well as
tumor markers were within normal limits. Abdominal imaging
studies (US, CT, MRCP) showed atrophy of the pancreas and
diffuse dilatation of the pancreatic duct. Endoscopic US (EUS)
revealed marked diffuse dilatation of the pancreatic duct and its side
branches containing high density endoluminal masses. Cytology
examination of trans EUS-FNA showed papillary adenoid cells with
malignant nuclear characteristics and mucous cytoplasm. The
patient underwent total pancreatectomywith partial gastrectomy and
had an uneventful postoperative period. RESULTS: Histology
confirmed the presence of diffuse intraductal papillary mucinous
neoplasm throughout the whole pancreatic duct as well as secondary
side branches with cell atypia, borderline carcinoma and some foci of
in situ carcinoma. CONCLUSION: Aggressive diagnostic and ther-
apeutic approach is mandatory in case of suspected IPMT and total
pancreatectomy may be considered as definite surgical treatment in
young patients with diffuse pancreatic disease.
32 METHODS TO EVALUATE THE SEVERITY OF
PANCREATIC EXOCRINE DYSFUNCTION IN CLINICAL
PRACTICE
O’Keefe SJD, Stevens S, Abedi M, Lee R, Zhou W, Divisions of
Gastroenterology, University of Pittsburgh, Pittsburgh, USA
INTRODUCTION AND AIM: In clinical practice, the treatment
of pancreatic exocrine insufficiency is empiric, based on trial of
commercial pancreatic supplements, as 72-h stool fat collections
are tedious and measurement of secretory function requires special-
ized skills. Our study was designed to investigate practical alter-
natives, based on endoscopic sampling and isotope labeling of
secretions and the absorption of isotope-labeled fat. PATIENTS
AND METHODS: Study population consisted of 13 chronic
pancreatitis patients (CP) and 5 healthy volunteers. CP were cate-
gorized as mild (5), moderate (2), or severe (6) disease state based on
CT, ERCP+/7 MRCP results. During endoscopy, 30 ml of a
polymeric liquid-formula diet containing protein, carbohydrate and
fat was infused into the second part of the duodenum adjacent to the
papilla of Vater. After 5 min, 3–5ml of pancreatic juice was aspirated
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for measurement of trypsin activity (Endo test). A double-lumen
perfusion/aspiration tube was then left in place in the 2nd/3rd part of
the duodenum allowing secretions to be collected in response to a 2-h
constant infusion of the same polymeric diet. In 7 patients (4 severe)
and all volunteers, an IV bolus of stable isotope (13C)-labeled
leucine was also given at time 0, and its uptake into secreted trypsin
measured over 120 min. On a separate day, the absorption and
metabolism of 14C-trioleic acid to 13CO2 was measured over 6 h.
RESULTS: None of the tests could discriminate patients with mild
structural changes on radiological imaging (RI) from normal. Only
the 2-h test could discriminate patients withmoderate changes onRI,
while all of the tests detected patients with severe disease.
CONCLUSION: Abnormalities in pancreatic enzyme synthesis,
enzyme secretion, and fat digestion can be readily detected by
isotope-labeling or endoscopic sampling of secreted trypsin, and by
isotope-labeled fat breath tests in patients with severe chronic
pancreatitis, but only the 2-h test discriminated patients with
moderate structural abnormalities on RI. As the endoscopic test can
easily be performed by any gastroenterologist, its use could be
recommended before committing a patient to life-long pancreatic
enzyme supplementation.
33 PANCREOJEJUNOSTOMY VERSUS
PANCREATICOGASTROSTOMY RECONSTRUCTION
FOLLOWING PANCREATICODUODENECTOMY: RESULTS
OF A PROSPECTIVE RANDOMIZED STUDY
Bassi C, Molinari E, Salvia R, Butturini G, Marcucci S, Falconi M,
Sartori N, Pederzoli P, Surgery, University of Verona, Verona, Italy
INTRODUCTION ANDAIM: Anastamotic failure is still the main
problem affecting the outcome of pancreaticoduodenectomy (PD).
There have been many techniques proposed for reconstructing the
pancreatico-digestive continuity, but there are few prospective and
randomized studies on the topic. PATIENTS AND METHODS:
Between 2002 and September 2004, 151 patients who underwent a
PD with ‘soft’ residual tissue were randomized to receive either a
pancreaticogastrostomy (Group PG, 69 cases) or an end-to-side
pancreaticojejunostomy (Group PJ, 82 cases). RESULTS: The two
treatment groups were not found to have any differences in regard to
vital statistics and underling diseases. Also, no significant differences
were found in the length of surgery (350 min IQR 307;380 in Group
PG, 360 IQR 330;362.5 in Group PJ) and need of intraoperative
blood units replacement (5 patients in each group).The post-
operative course had a comprehensive incidence of complications of
39% (34.8% in Group PG, 42.7% in Group PJ; p=n.s.). The most
frequent complication was pancreatic fistula (defined as a daily
output of430 ml rich in amylase content for at least 7 days from the
4th postoperative day and delay in the hospital stay with significant
clinical impact) and occurred in 14.5% of patients (13% in Group
PG and 15.8% in Group PJ, p=n.s.). Ten (6.6%) patients, five in
each group, required reoperation and the postoperativemortality rate
was 0.6% (1 patient in group PJ). Looking at the single surgical
complications no differences were reported in the frequence of
enteric fistula (5.8% in PG vs 8.5% in PJ), pancreatitis (1.4% in PG
vs 4.9% in PJ) and postoperative bleeding (4.3% in PG vs 7.3% in
PJ). A significant difference was detected in favour of the PG
reconstruction for postoperative collections (defined as a US or CT
scan detection of fluid measuring at least 5 cm in diameter, 10.1% vs
26.8%; p=0.01), delayed gastric emptying (DGE) (2.9% vs 12.2%;
p=0.03) and biliary fistula (nil vs 8.5%; p=0.01). The median
postoperative hospital stay was the same in the two groups (13 days,
Group PG with IQR 10;19 and Group PJ with IQR
10;20.75).According to the International Study Group on Post
Operative Pancreatic Fistula Definition (unpublished data), 31
patients were suspected to suffer from a pancreatic fistula. Nine
patients showed ‘transient’ fistulas (GradeA) with no clinical impact,
no specific treatment and no delay in hospital discharge (4 patients in
PG and 5 in PJ); 10 patients (6 patients in PG and 4 in PJ) were
suffering from Grade B fistula with clinical impact (need of specific
treatment, delay in discharge or readmission or discharged with
drains in situ); 12 patients (3 patients in PG and 9 in PJ; p=n.s.)
experienced Grade C fistula (aggressive management, often in an
ICU setting and frequent need for percutaneous drainage or surgery
with high risk of death and an extended hospital stay). CONCLU-
SION: Despite a trend in favour of PG, the two methods studied did
not reveal any significant differences in the overall complications rate.
Biliary fistulas, postoperative collections and DGE are significantly
reduced in the group with PG. The rate of pancreatic fistula is similar
also considering the different clinical impact of the complication.
34 FROZEN SECTIONING OF THE PANCREATIC CUT
SURFACE DURING PANCREATECTOMY FOR
INTRADUCTAL PAPILLARY AND MUCINOUS TUMOURS
(IPMT) IS USEFUL AND RELIABLE: A PROSPECTIVE
EVALUATION
Sauvanet A2, Couvelard A1, Kianmanesh AR2, Hammel P3, Colnot
N1, Le´vy PP3, Ruszniewski P3, Bedossa P1, Belghiti J2, (1) Pathology,
Hospital Beaujon; (2) Digestive Surgery, Hospital Beaujon;
(3) Gastroenterology, Hospital Beaujon, Clichy, France
INTRODUCTION AND AIM: Frozen sectioning (FS) of
pancreatic cut surface is proposed to perform pancreatectomy suited
to IPMT topography. This study aimed to evaluate FS accuracy and
its influence on surgery. PATIENTS AND METHODS: From
1996, 154 pancreatectomies were performed for IPMT. There were
56 BD variants and 98 MD or mixed variants, with mild or no
dysplasia (adenoma [A]; n=55), moderate dysplasia (border-line
[B]; n=27), carcinoma in situ (CIS; n=35) or infiltrating carcinoma
(IC; n=37). FS was used except in one-step total or completion
pancreatectomy. FS was performed in 90 pancreaticoduodenec-
tomies (1–4 successive FS; total=132), 23 distal pancreatectomies
(1–2 FS; total=26) and 14 medial pancreatectomies (2–4 FS;
total=30). Pancreatectomy was extended if FS revealed at least mild
dysplasia on MD or BLD on BD (‘significant’ lesions). RESULTS:
FS revealed that MD epithelium was normal (n=120), eroded
(n=15), or comprised A (n=33), B (n=11) or CIS (n=5); BD
epithelium was normal (n=106), or comprised A (n=65), B (n=8)
or CIS (n=5). FS revealed IC in 4 cases. Definitive examination
corroborated FS in 176/188 (94%) cases. The 54/188 (29%) FS
comprising ‘significant’ lesions resulted in 46 additional resections in
38 (30%) patients; 8 patients did not have additional resection due to
advanced IC or technical difficulties. Seven of the 134 FS without
‘significant’ lesions were followed by additional resection due to
macroscopic suspicion of another localization. Results of FS resulted
in inadequate pancreatectomy in 4 (3%) patients. CONCLUSION:
FS changes the extent of pancreatectomy for IPMT in 30% of
patients and results in adequate resection in 97% of them.
35 TIME-ELAPSED INTRAVITAL MICROSCOPY: AN
INNOVATIVE TECHNOLOGY TO ASSESS LEUKOCYTE
MIGRATION IN THE INTRA- AND EXTRAVASCULAR SPACE
Ryschich E1, Lizdenis P1, Kerkadze U1, Knaebel HP1, Gross W2,
Gebhard MM2 Bu¨chler MW1, Schmidt J1, (1) Department of
Surgery; (2) Department of Experimental Surgery, University of
Heidelberg, Heidelberg, Germany
INTRODUCTION AND AIM: The ability for active movement is
an important feature of leukocytes. Blockage or activation of leuko-
cyte locomotion may be used to control acute inflammation and
immune response. Here, we utilized a novel technique which
combines intravital microscopy and time-elapsed video documen-
tation to investigate the action of pro- and anti-inflammatory
substances on leukocyte movement in vivo. PATIENTS AND
METHODS: Intravital microscopy of mesenteric venules was
performed in 24 male Lewis rats using digital video recording and
time-elapsed image compression. The numbers of rolling and
crawling leukocytes, leukocyte transmigration, leukocyte velocity and
the number of migrating leukocytes were measured every 5 min over
60min. The local effect of LPS (10 mg/ml) andTNF-alpha (1 mg/ml)
on intra- and extravascular leukocyte movement was investigated.
RESULTS: Baseline measurement showed a mean leukocyte veloc-
ity of 7.9+ 4.2 mm/min and a mean percentage of migrating cells of
42+ 28%.TNF-alpha caused a significant increase of the number of
crawling leukocytes, mean leukocyte velocity to 14.2+ 3.9 mm/min
(p50.05) and the percentage of migrating cells to 82.0 + 20.0%
(p50.05). LPS significantly increased leukocyte rolling and the
percentage of migrating leukocytes, but did not alter mean leukocyte
velocity. Although the present technology allowed a detailed video
documentation of transendothelial migration, there were no signifi-
cant differences of leukocyte transmigration after treatment with LPS
and TNF-alpha. CONCLUSION: LPS and TNF-alpha re-activate
the leukocyte locomotion, but not the leukocyte transmigration.
Additionally, TNF-alpha enhances velocity of leukocyte movement.
The method of time-elapsed intravital microscopy represents an
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innovative technology for the investigation of leukocyte movement in
the intravascular and extravascular space.
36 MANAGEMENT AND RESULTS OF PANCREATIC
LEAKAGE AFTER PANCREATIC RESECTION
Behrbohm J, GumppK,UhlmannD,Weber E,Hauss J,Witzigmann
H, Chirurgie II, Universita¨tsklinikum Leipzig, Leipzig, Germany
INTRODUCTION AND AIM: The incidence of leakage/fistula of
the pancreatoenterostomy is approximately 1–16%. The mortality in
patients with extended leakages is up to 40%. Nevertheless only few
data exist concerning therapeutic management of insufficiency of the
pancreatic anastomosis. PATIENTS AND METHODS: Between
01/1994 and 10/2004 we treated 910 patients with pancreatic
diseases, in 620 we performed pancreatectomy (75% pancreatico-
duodenectomy, 11% left resection, 14% others). In 89% we
performed pancreatic anastomosis. As there is no agreed definition of
pancreatic leakage, we defined two groups: manifest leakage
(pancreas juice in drainage, radiological signs combined with sepsis,
peritonitis) and mild fistula (45-times elevated values of amylase/
lipase in the drainage, secretion 450 ml/d, 410 days post-
operatively, no peritonitis). Data were collected prospectively. The
pancreatic anastomosis was performed in 1995–1999 as end-to-side
pancreatojejunostomy, and in 2000–2004 as telescope-anastomosis
with pancreatic duct drainage tube. RESULTS: In 35 patients
(6.3%) we found leakage/fistula after pancreatojejunostomy: 23
patients (4.2%) with manifest leakage (including 2 patients with
simultanous fistula of the bile duct), 12 (2.1%) with mild fistula. All
23 patients with manifest leakage and 5 patients with fistula were
reoperated. The following procedures were performed: Removal of
the anastomosis and lavage (n=15), oversewing with lavage (n=9),
construction of a new anastomosis (n=3), removal of the remaining
pancreas (n=1). All 12 patients withmild fistula survived, while 12 of
23 patients with manifest leakage died. This means an average
mortality of 34.3% (12/35). On average the patients who died in the
follow-up had relaparotomy on the 9th postoperative day, the
surviving patients were reoperated on postoperative day 2.
Comparing the periods 1995–1999 vs 2000–2004 we found that the
rate of leakage/fistula was comparable (6.5% vs 5.4%), extended
insufficiencies were more frequent in the first period (17 vs 6).
CONCLUSION: The therapeutic management of leakages/fistulas
of the pancreatojejunostomy depends on the severity. In our 10-year
study the overall rate of leakage and fistula stayed the same, while
severe leakages decreased in 2000–2004. Decisive in the ther-
apeutical management are early relaparotomies before sepsis is
generalized. The most frequent operation was removal of the
anastomosis. Construction of a new anastomosis is only possible in
the early stage of insufficiency. ‘Completion pancreatectomy’ is no
longer the therapy of choice.
37 INSTITUTIONAL VOLUME DETERMINES THE
OUTCOME OF NON-PANCREATIC PERIAMPULLARY
LESIONS AFTER PANCREATICODUODENECTOMY
Lam CM1, Fan ST1, Yuen A2, Wai A2, (1) Surgery, Queen Mary
Hospital, Hong Kong; (2) Central Surgical Audit Unit, Hospital
Authority, Hong Kong SAR, China
INTRODUCTION AND AIM: A high hospital mortality rate was
found in non-pancreatic periampullary lesions after pancreatico-
duodenectomy (PD). The aim of the present study was to investigate
the risk factors responsible for hospital mortality and the effect of
institutional volume on hospital mortality. PATIENTS AND
METHODS: This was a retrospective analysis of all the patients who
underwent PD for non-pancreatic periampullary lesions in all
Hospital Authority (HA) hospitals from 1998 to 2002 inHongKong.
The hospitals were divided into two groups, namely, those with49
PD per year and those with59 PD per year, for comparison of short-
term outcomes. RESULTS: There were 111 men (53.4%) and 97
women (46.6%) with a mean age of 63.8+/7 11.5 years. 62% of the
patients had ampullary lesions, 28.8% had common bile duct lesions,
and 9.1% had duodenal lesions. Benign pathology was found in
11.5%of the patients whereas 85%had definitemalignancy. Pylorus-
preserving PDwas done in 45.7% of the patients while the remaining
54.3% had standard PD. The hospital mortality and morbidity rates
were 11.1% and 58.7%, respectively. Three preoperative factors,
namely, high physiological score (p=0.008), low preoperative albu-
min concentration (p=0.014), and presence of diabetes mellitus
(p=0.039) were independent variables for hospital mortality. The
hospital mortality rate was 2.2% in hospitals with volume load 49
PD per year, whereas a mortality rate of 17.8% was observed in
hospitals with volume load 59 PD per year (p=0.000). There was
no significant difference in the overall complication rate. However,
severe complications like pancreaticojejunostomy leakage (25.4% vs
12.2%, p=0.018) and reoperation rate (19.5% vs 7.8%, p=0.017)
were significantly higher in low-volume hospitals. Furthermore, the
length of stay in intensive care unit, postoperative length of stay and
total length of stay were significantly longer in low-volume hospitals.
CONCLUSION: High physiological score, low preoperative albu-
min concentration and presence of diabetes mellitus were indepen-
dent predictors for hospital mortality after PD in patients with non-
pancreatic periampullary lesions. Better postoperative outcomes
were observed in hospitals performing49 PD per year.
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